Sickle Cell Disease in Sub-Saharan Africa: Data Coordinating Center (U24)
The summary for the Sickle Cell Disease in Sub-Saharan Africa: Data Coordinating Center (U24) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Sickle Cell Disease in Sub-Saharan Africa: Data Coordinating Center (U24): The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications that propose to develop a Sickle Cell Disease (SCD) in Sub-Saharan Africa (SSA) Data Coordinating Center (DCC) that will support the activities of the SCD in SSA Collaborative Consortium (RFA-HL-17-006). The Collaborative Consortium comprised of a Consortium Hub and at least two additional Collaborating Sites will be responsible for developing the infrastructure for a future SCD in SSA Research Network.
Federal Grant Title: | Sickle Cell Disease in Sub-Saharan Africa: Data Coordinating Center (U24) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-HL-17-007 |
Type of Funding: | Cooperative Agreement |
CFDA Numbers: | 93.839 |
CFDA Descriptions: | Blood Diseases and Resources Research |
Current Application Deadline: | Feb 26, 2016 |
Original Application Deadline: | Feb 26, 2016 |
Posted Date: | Sep 1, 2015 |
Creation Date: | Sep 1, 2015 |
Archive Date: | Mar 28, 2016 |
Total Program Funding: | |
Maximum Federal Grant Award: | none |
Minimum Federal Grant Award: | none |
Expected Number of Awards: | 1 |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Organizations); Non-domestic (non-U.S.) Entities (Foreign Institutions) in African countries are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations in African countries are eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed. - Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-17-007.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
National Institutes of Health 301-496-3405 - Similar Government Grants
- • An Intergenerational Precision Medicine Research Program for the Study of Factor VIII Immu...
- • New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional)
- • Limited Competition: Sickle Pan-African Research Consortium Clinical Coordinating Center (...
- • Sickle Pan-African Research Consortium Collaborative Sites (U01 Clinical Trial Optional)
- • Limited Competition: Sickle Africa Data Coordinating Center (U24 Clinical Trial Optional)
- • Improved Therapy for Hemophilia and Hereditary Bleeding Disorders
- • Clinical Hematology Research Career Development Program (K12)
- • Molecular Mechanisms Underlying Diamond-Blackfan Anemia and Other Congenital Bone Marrow F...
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)